+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Humanized Mouse Model Market 2024-2028

  • PDF Icon

    Report

  • 160 Pages
  • November 2023
  • Region: Global
  • TechNavio
  • ID: 5031202
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The humanized mouse model market is forecasted to grow by USD 108.6 million during 2023-2028, accelerating at a CAGR of 10.22% during the forecast period. The report on the humanized mouse model market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing adoption of personalized medicine, innovative applications of humanized mouse models, and advancements in genetic engineering technologies.

The humanized mouse model market is segmented as below:

By End-user

  • Pharmaceutical and biotechnology companies
  • CROs
  • Academic and research institutions

By Product

  • Genetically humanized mouse model
  • Cell-based humanized mouse model

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the strategic alliances of vendors as one of the prime reasons driving the humanized mouse model market growth during the next few years. Also, increasing production of MABs and emergence of whole animal imaging will lead to sizable demand in the market.

The report on the humanized mouse model market covers the following areas:

  • Humanized mouse model market sizing
  • Humanized mouse model market forecast
  • Humanized mouse model market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading humanized mouse model market vendors that include Altogen labs, Aragen Life Sciences Pvt. Ltd., Biocytogen, BioSafety Research Center Inc., Champions Oncology Inc., Charles River Laboratories International Inc., Creative Biolabs, Cyagen Biosciences, Gempharmatech Co. Ltd., genOway, HBM Holdings Ltd., Hera Biolabs Inc., ingenious targeting laboratory, Inotiv, Inc., JANVIER LABS, JSR Corp., Oncodesign SA, Ozgene Pty Ltd., PerkinElmer Inc., and Pharmatest services. Also, the humanized mouse model market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global humanized mouse model market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global humanized mouse model market 2018 - 2022 ($ million)
4.2 End-user Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.3 Product Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user
6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
Exhibit 34: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
6.4 CROs - Market size and forecast 2023-2028
Exhibit 38: Chart on CROs - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on CROs - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on CROs - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on CROs - Year-over-year growth 2023-2028 (%)
6.5 Academic and research institutions - Market size and forecast 2023-2028
Exhibit 42: Chart on Academic and research institutions - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Academic and research institutions - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Academic and research institutions - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Academic and research institutions - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by End-user
Exhibit 46: Market opportunity by End-user ($ million)
Exhibit 47: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Product
7.1 Market segments
Exhibit 48: Chart on Product - Market share 2023-2028 (%)
Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
Exhibit 50: Chart on Comparison by Product
Exhibit 51: Data Table on Comparison by Product
7.3 Genetically humanized mouse model - Market size and forecast 2023-2028
Exhibit 52: Chart on Genetically humanized mouse model - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Genetically humanized mouse model - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Genetically humanized mouse model - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Genetically humanized mouse model - Year-over-year growth 2023-2028 (%)
7.4 Cell-based humanized mouse model - Market size and forecast 2023-2028
Exhibit 56: Chart on Cell-based humanized mouse model - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Cell-based humanized mouse model - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Cell-based humanized mouse model - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Cell-based humanized mouse model - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Product
Exhibit 60: Market opportunity by Product ($ million)
Exhibit 61: Data Table on Market opportunity by Product ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Exhibit 87: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 France - Market size and forecast 2023-2028
Exhibit 91: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on France - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Altogen labs
Exhibit 111: Altogen labs - Overview
Exhibit 112: Altogen labs - Product / Service
Exhibit 113: Altogen labs - Key offerings
12.4 Aragen Life Sciences Pvt. Ltd.
Exhibit 114: Aragen Life Sciences Pvt. Ltd. - Overview
Exhibit 115: Aragen Life Sciences Pvt. Ltd. - Product / Service
Exhibit 116: Aragen Life Sciences Pvt. Ltd. - Key news
Exhibit 117: Aragen Life Sciences Pvt. Ltd. - Key offerings
12.5 Biocytogen
Exhibit 118: Biocytogen - Overview
Exhibit 119: Biocytogen - Product / Service
Exhibit 120: Biocytogen - Key offerings
12.6 BioSafety Research Center Inc.
Exhibit 121: BioSafety Research Center Inc. - Overview
Exhibit 122: BioSafety Research Center Inc. - Product / Service
Exhibit 123: BioSafety Research Center Inc. - Key offerings
12.7 Champions Oncology Inc.
Exhibit 124: Champions Oncology Inc. - Overview
Exhibit 125: Champions Oncology Inc. - Product / Service
Exhibit 126: Champions Oncology Inc. - Key news
Exhibit 127: Champions Oncology Inc. - Key offerings
12.8 Charles River Laboratories International Inc.
Exhibit 128: Charles River Laboratories International Inc. - Overview
Exhibit 129: Charles River Laboratories International Inc. - Business segments
Exhibit 130: Charles River Laboratories International Inc. - Key news
Exhibit 131: Charles River Laboratories International Inc. - Key offerings
Exhibit 132: Charles River Laboratories International Inc. - Segment focus
12.9 Creative Biolabs
Exhibit 133: Creative Biolabs - Overview
Exhibit 134: Creative Biolabs - Product / Service
Exhibit 135: Creative Biolabs - Key offerings
12.10 Cyagen Biosciences
Exhibit 136: Cyagen Biosciences - Overview
Exhibit 137: Cyagen Biosciences - Product / Service
Exhibit 138: Cyagen Biosciences - Key offerings
12.11 Gempharmatech Co. Ltd.
Exhibit 139: Gempharmatech Co. Ltd. - Overview
Exhibit 140: Gempharmatech Co. Ltd. - Product / Service
Exhibit 141: Gempharmatech Co. Ltd. - Key offerings
12.12 genOway
Exhibit 142: genOway - Overview
Exhibit 143: genOway - Product / Service
Exhibit 144: genOway - Key offerings
12.13 HBM Holdings Ltd.
Exhibit 145: HBM Holdings Ltd. - Overview
Exhibit 146: HBM Holdings Ltd. - Product / Service
Exhibit 147: HBM Holdings Ltd. - Key offerings
12.14 Hera Biolabs Inc.
Exhibit 148: Hera Biolabs Inc. - Overview
Exhibit 149: Hera Biolabs Inc. - Product / Service
Exhibit 150: Hera Biolabs Inc. - Key offerings
12.15 ingenious targeting laboratory
Exhibit 151: ingenious targeting laboratory - Overview
Exhibit 152: ingenious targeting laboratory - Product / Service
Exhibit 153: ingenious targeting laboratory - Key offerings
12.16 JSR Corp.
Exhibit 154: JSR Corp. - Overview
Exhibit 155: JSR Corp. - Business segments
Exhibit 156: JSR Corp. - Key offerings
Exhibit 157: JSR Corp. - Segment focus
12.17 PerkinElmer Inc.
Exhibit 158: PerkinElmer Inc. - Overview
Exhibit 159: PerkinElmer Inc. - Business segments
Exhibit 160: PerkinElmer Inc. - Key news
Exhibit 161: PerkinElmer Inc. - Key offerings
Exhibit 162: PerkinElmer Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 163: Inclusions checklist
Exhibit 164: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 165: Currency conversion rates for US$
13.4 Research methodology
Exhibit 166: Research methodology
Exhibit 167: Validation techniques employed for market sizing
Exhibit 168: Information sources
13.5 List of abbreviations
Exhibit 169: List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 6: Executive Summary - Chart on Market Segmentation by Product
Exhibit 7: Executive Summary - Chart on Incremental Growth
Exhibit 8: Executive Summary - Data Table on Incremental Growth
Exhibit 9: Executive Summary - Chart on Vendor Market Positioning
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
Exhibit 12: Offerings of vendors included in the market definition
Exhibit 13: Market segments
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 18: Historic Market Size - Data Table on global humanized mouse model market 2018 - 2022 ($ million)
Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
Exhibit 34: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibit 38: Chart on CROs - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on CROs - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on CROs - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on CROs - Year-over-year growth 2023-2028 (%)
Exhibit 42: Chart on Academic and research institutions - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Academic and research institutions - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Academic and research institutions - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Academic and research institutions - Year-over-year growth 2023-2028 (%)
Exhibit 46: Market opportunity by End-user ($ million)
Exhibit 47: Data Table on Market opportunity by End-user ($ million)
Exhibit 48: Chart on Product - Market share 2023-2028 (%)
Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
Exhibit 50: Chart on Comparison by Product
Exhibit 51: Data Table on Comparison by Product
Exhibit 52: Chart on Genetically humanized mouse model - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Genetically humanized mouse model - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Genetically humanized mouse model - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Genetically humanized mouse model - Year-over-year growth 2023-2028 (%)
Exhibit 56: Chart on Cell-based humanized mouse model - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Cell-based humanized mouse model - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Cell-based humanized mouse model - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Cell-based humanized mouse model - Year-over-year growth 2023-2028 (%)
Exhibit 60: Market opportunity by Product ($ million)
Exhibit 61: Data Table on Market opportunity by Product ($ million)
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibit 87: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibit 91: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
Exhibit 107: Overview on factors of disruption
Exhibit 108: Impact of key risks on business
Exhibit 109: Vendors covered
Exhibit 110: Matrix on vendor position and classification
Exhibit 111: Altogen labs - Overview
Exhibit 112: Altogen labs - Product / Service
Exhibit 113: Altogen labs - Key offerings
Exhibit 114: Aragen Life Sciences Pvt. Ltd. - Overview
Exhibit 115: Aragen Life Sciences Pvt. Ltd. - Product / Service
Exhibit 116: Aragen Life Sciences Pvt. Ltd. - Key news
Exhibit 117: Aragen Life Sciences Pvt. Ltd. - Key offerings
Exhibit 118: Biocytogen - Overview
Exhibit 119: Biocytogen - Product / Service
Exhibit 120: Biocytogen - Key offerings
Exhibit 121: BioSafety Research Center Inc. - Overview
Exhibit 122: BioSafety Research Center Inc. - Product / Service
Exhibit 123: BioSafety Research Center Inc. - Key offerings
Exhibit 124: Champions Oncology Inc. - Overview
Exhibit 125: Champions Oncology Inc. - Product / Service
Exhibit 126: Champions Oncology Inc. - Key news
Exhibit 127: Champions Oncology Inc. - Key offerings
Exhibit 128: Charles River Laboratories International Inc. - Overview
Exhibit 129: Charles River Laboratories International Inc. - Business segments
Exhibit 130: Charles River Laboratories International Inc. - Key news
Exhibit 131: Charles River Laboratories International Inc. - Key offerings
Exhibit 132: Charles River Laboratories International Inc. - Segment focus
Exhibit 133: Creative Biolabs - Overview
Exhibit 134: Creative Biolabs - Product / Service
Exhibit 135: Creative Biolabs - Key offerings
Exhibit 136: Cyagen Biosciences - Overview
Exhibit 137: Cyagen Biosciences - Product / Service
Exhibit 138: Cyagen Biosciences - Key offerings
Exhibit 139: Gempharmatech Co. Ltd. - Overview
Exhibit 140: Gempharmatech Co. Ltd. - Product / Service
Exhibit 141: Gempharmatech Co. Ltd. - Key offerings
Exhibit 142: genOway - Overview
Exhibit 143: genOway - Product / Service
Exhibit 144: genOway - Key offerings
Exhibit 145: HBM Holdings Ltd. - Overview
Exhibit 146: HBM Holdings Ltd. - Product / Service
Exhibit 147: HBM Holdings Ltd. - Key offerings
Exhibit 148: Hera Biolabs Inc. - Overview
Exhibit 149: Hera Biolabs Inc. - Product / Service
Exhibit 150: Hera Biolabs Inc. - Key offerings
Exhibit 151: ingenious targeting laboratory - Overview
Exhibit 152: ingenious targeting laboratory - Product / Service
Exhibit 153: ingenious targeting laboratory - Key offerings
Exhibit 154: JSR Corp. - Overview
Exhibit 155: JSR Corp. - Business segments
Exhibit 156: JSR Corp. - Key offerings
Exhibit 157: JSR Corp. - Segment focus
Exhibit 158: PerkinElmer Inc. - Overview
Exhibit 159: PerkinElmer Inc. - Business segments
Exhibit 160: PerkinElmer Inc. - Key news
Exhibit 161: PerkinElmer Inc. - Key offerings
Exhibit 162: PerkinElmer Inc. - Segment focus
Exhibit 163: Inclusions checklist
Exhibit 164: Exclusions checklist
Exhibit 165: Currency conversion rates for US$
Exhibit 166: Research methodology
Exhibit 167: Validation techniques employed for market sizing
Exhibit 168: Information sources
Exhibit 169: List of abbreviations

Executive Summary

The analyst recognizes the following companies as the key players in the global humanized mouse model market: Altogen labs, Aragen Life Sciences Pvt. Ltd., Biocytogen, BioSafety Research Center Inc., Champions Oncology Inc., Charles River Laboratories International Inc., Creative Biolabs, Cyagen Biosciences, Gempharmatech Co. Ltd., genOway, HBM Holdings Ltd., Hera Biolabs Inc., ingenious targeting laboratory, Inotiv, Inc., JANVIER LABS, JSR Corp., Oncodesign SA, Ozgene Pty Ltd., PerkinElmer Inc., and Pharmatest services.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the strategic alliances of vendors.'

According to the report, one of the major drivers for this market is the growing adoption of personalized medicine.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Altogen labs
  • Aragen Life Sciences Pvt. Ltd.
  • Biocytogen
  • BioSafety Research Center Inc.
  • Champions Oncology Inc.
  • Charles River Laboratories International Inc.
  • Creative Biolabs
  • Cyagen Biosciences
  • Gempharmatech Co. Ltd.
  • genOway
  • HBM Holdings Ltd.
  • Hera Biolabs Inc.
  • ingenious targeting laboratory
  • Inotiv
  • Inc.
  • JANVIER LABS
  • JSR Corp.
  • Oncodesign SA
  • Ozgene Pty Ltd.
  • PerkinElmer Inc.
  • Pharmatest services

Related Topics

Related Reports

Global Humanized Mouse & Rat Model Market by Type (Humanized Mouse Model, Humanized Rat Model), Application (Hematopoiesis, Immunology & Infectious Diseases, Neuroscience), End-User - Forecast 2024-2030 - Product Image

Global Humanized Mouse & Rat Model Market by Type (Humanized Mouse Model, Humanized Rat Model), Application (Hematopoiesis, Immunology & Infectious Diseases, Neuroscience), End-User - Forecast 2024-2030

  • Report
  • 186 Pages
  • Global
From
Humanized Mouse Model Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Humanized Mouse Model Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 112 Pages
  • Global
From
Oncology Mice Models Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Oncology Mice Models Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 250 Pages
  • Global
Global Rat and Mouse Model Market Size, Share & Trends Analysis Report by Model and Services, Application (Cardiovascular Diseases, Genetic Diseases), End-use (Pharmaceutical & Biotechnology Companies), Region, and Segment Forecasts, 2024-2030 - Product Image

Global Rat and Mouse Model Market Size, Share & Trends Analysis Report by Model and Services, Application (Cardiovascular Diseases, Genetic Diseases), End-use (Pharmaceutical & Biotechnology Companies), Region, and Segment Forecasts, 2024-2030

  • Report
  • 130 Pages
  • Global
From
Cell-based Humanized Mouse Models Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type - Product Image

Cell-based Humanized Mouse Models Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 84 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.